Not all patients with CLL demand therapy. Irrespective of all current advancements, the iwCLL continue to recommends watchful observation for individuals with asymptomatic condition.86 This suggestion relies on no less than two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Equally trials concluded ... https://lemmye963koq3.targetblogs.com/profile